Currently Viewing:
Newsroom
Currently Reading
Bidens Celebrate Progress, Highlight Need for More at Biden Cancer Summit
September 21, 2018 – Jaime Rosenberg
PhRMA Tries to Use Opioid Bill to Shift Part D Costs to Medicare
September 21, 2018 – Mary Caffrey
More Data Necessary to Determine Best Treatment Option in Basal Cell Carcinoma
September 21, 2018 – Samantha DiGrande
5 Things to Know About Obesity in the United States
September 21, 2018 – Jaime Rosenberg
This Week in Managed Care: September 21, 2018
September 21, 2018
What We're Reading: MSKCC AI Startup; AMA and Patient Privacy; GOP Healthcare Message
September 21, 2018 – AJMC Staff
AJMC® in the Press, September 21, 2018
September 21, 2018 – AJMC Staff
US Women Have Higher Risk of Dying Prematurely, Report Says
September 20, 2018 – Allison Inserro
Bipartisan Group of Senators Drafts Legislation to End Surprise Medical Bills
September 20, 2018 – Jaime Rosenberg

NCCN Releases New Guidelines for Most Common Gynecologic Cancer

Samantha DiGrande
The National Comprehensive Cancer Network (NCCN) released this week new treatment guidelines for patients for 2 uterine cancers, endometrial cancer, the most common gynecologic cancer, and a rare cancer called uterine sarcoma.
The National Comprehensive Cancer Network (NCCN) released this week new treatment guidelines for patients for 2 uterine cancers, endometrial cancer, the most common gynecologic cancer, and a rare cancer called uterine sarcoma. 

In the release of the guidelines, NCCN notes that while the number of deaths from most cancers are declining in the United States, it is rising for endometrial cancer, which is the most common type of uterine cancer impacting more than 63,000 new patients every year. In 2018 alone, more than 11,000 women are expected to die from the disease. 

“The NCCN Guidelines for Patients answer a real need for people with cancer and their loved ones, who want a better understanding of the medical decisions facing them. These guidelines go beyond a basic overview, to truly explain, in plain language, what experts agree are the best, most up-to-date treatment approaches,” said Robert W. Carlson, MD, CEO of NCCN, in a statement.

A multidisciplinary team including surgeons, radiation oncologists, pathologists, and other experts from leading academic cancer centers worked to create the guidelines. The Guidelines for Patients feature content adapted from the NCCN Clinical Practice Guidelines in Oncology in a more patient-friendly format including a glossary of terms and medical illustrations. 

Additionally, the guidelines are endorsed by Facing Our Risk of Cancer Empowered (FORCE). Currently, the NCCN library of patient guidelines includes more than 40 different cancer types, including breast, colon, lung, and prostate cancers. 

“It’s very useful for patients to be aware of what to expect from their treatment, based on state-of-the-art consensus. I want people to know, if they’re diagnosed with endometrial cancer, they should see a gynecologic oncologist, and not just rely on treatment from a general physician,” said Nabeem Abu-Rustum, MD, Memorial Sloan Kettering Cancer Center and Vice Chair of the NCCN Guidelines Panel for Cervical, Uterine, and Vulvar Cancers, in a statement.

Related Articles

ASCO and NCCN Release Guidelines on Managing Immunotherapy-Related Toxicities
NCCN's New Guidelines Promote Better Cancer Care for People With HIV
Making Progress, or Headed for Crisis? NCCN Keynotes Offer Contrasting Views of US Cancer Care
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!